Quantum leap in the reliability of mass spectrometry-based proteomics
Modern mass spectrometry systems enable scientists to routinely determine the quantitative composition of cells or tissue samples. However, different analysis software packages often produce different results from the same raw data. An international team of researchers led by Professor Stefan Tenzer from the Mainz University Medical Center has now addressed this problem.
In the framework of an international collaboration with leading laboratories worldwide, the team has compared and modified various analysis software packages to ensure that the different software solutions produce consistent results. A wide range of laboratories around the world are benefiting from this work, which enables researchers to analyze or compare the results of quantitative proteomics assays in a standardized way. This is crucial to detect certain organic diseases, such as cancer, at an early stage. The results of Tenzer and his team have now been published in the highly respected academic journal, Nature Biotechnology.
When doctors want to find the cause of a particular illness, they have to take samples of cells or bodily fluids. These samples are then analyzed by modern Omics techniques which enable to reproducibly quantify thousands of proteins across large numbers of samples to identify novel biomarkers for diseases. The analysis of these highly complex datasets critically depends on specialized software packages. Unfortunately, different software packages sometimes deliver divergent results from the same raw data, thus complicating the analysis.
This is exactly the problem that Professor Stefan Tenzer and his team from the Institute of Immunology at the University Medical Center of Johannes Gutenberg University Mainz (JGU) set out to resolve. "We wanted to find a way of optimally comparing samples, even when different analysis software sometimes produces deviating results," explained Tenzer. For his latest project he used two defined samples with precisely defined ratios of constituents.
The bioinformatics specialists in Tenzer's team, Dr. Pedro Navarro and Dr. Jörg Kuharev, developed a specialist piece of software, termed LFQbench. This allowed the team to study the differences between the various analysis programs in detail. "Using LFQbench, we were able to show that the results delivered by the various programs differed significantly," explained Navarro. "This finding alone has significant impact for the scientific community.
But we have taken the project a step further: Our close collaboration with the developers of the individual programs enabled them to modify and improve their analysis packages so that they now produce highly convergent results," added Tenzer. This broadens the scope of applications of the mass spectrometry technique known as quantitative proteomics. A proteome is the entirety of proteins expressed by a cell. "This means that in the future, mass spectrometry will be able to provide even more benefits both in basic research and as a potential diagnostic tool," Tenzer pointed out.
"This development represents a breakthrough for mass spectrometry-based quantitative proteomics and makes this method increasingly important as a standard procedure for use in the diagnosis of various disorders, such as cancer or allergies," emphasized the Chief Scientific Officer of the Mainz University Medical Center, Professor Ulrich Förstermann. "I am particularly proud that our researchers are delivering applied research with such significant impact."
The pioneering results were achieved under the aegis of the technology platform "Mass Spectrometry and Quantitative Proteomics" based at the Research Center for Immunotherapy (FZI) at Johannes Gutenberg University Mainz (JGU). "This success demonstrates the necessity of combining different areas of expertise in technology platforms at the University Medical Center. Without central support, it is nowadays almost impossible to accomplish achievements of this kind," said Professor Hansjörg Schild, Director of the Institute of Immunology and coordinator of the FZI for many years.
Over recent years, Professor Stefan Tenzer and his team in Mainz have developed several improvements to the techniques used for mass spectrometry-based quantitative proteomics. These methods reproducibly detect and quantify thousands of proteins in samples of cells, tissues, or bodily fluids, and enable researchers to identify proteins that are differentially expressed. "The years of work within the technology platform, especially in international joint projects, have paid off in terms of this quantum leap forward in mass spectrometry-based quantitative proteomics," concluded Tenzer.
"A multicenter study benchmarks software tools for label-free proteome quantification"
Pedro Navarro1,11, Jörg Kuharev1,11, Ludovic C Gillet2, Oliver M. Bernhardt3, Brendan MacLean4, Hannes L. Röst2, Stephen A. Tate5, Chih-Chiang Tsou6, Lukas Reiter3, Ute Distler1, George Rosenberger2,7, Yasset Perez-Riverol8, Alexey I. Nesvizhskii6,9, Ruedi Aebersold2,10, Stefan Tenzer1
1 Institute of Immunology, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany
2 Department of Biology, Institute of Molecular Systems Biology, Eidgenoessische Technische Hochschule (IMSB-ETH) Zurich, Zurich, Switzerland
3 Biognosys AG, Schlieren, Switzerland
4 Department of Genome Sciences, University of Washington, Seattle, Washington, USA
5 AB Sciex, Concord, Ontario, Canada
6 Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA
7 PhD Program in Systems Biology, University of Zurich and Eidgenoessische Technische Hochschule (ETH) Zurich, Zurich, Switzerland
8 European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK
9 Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA
10 Faculty of Science, University of Zurich, Zurich, Switzerland
11 These authors contributed equally to this work.
Professor Stefan Tenzer
Head of the Core Facility for Mass Spectrometry
Institute of Immunology
Mainz University Medical Center
Oliver Kreft, Press and Public Relations, Mainz University Medical Center
phone +49 6131 17-7424, fax +49 6131 17-3496, e-mail: firstname.lastname@example.org
Petra Giegerich | idw - Informationsdienst Wissenschaft
New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences
The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.
During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....
The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.
Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
21.11.2017 | Physics and Astronomy
21.11.2017 | Physics and Astronomy
21.11.2017 | Life Sciences